187 related articles for article (PubMed ID: 70501)
1. Specificity of cytotoxic effector cells directed against trinitrobenzene sulfonate-modified syngeneic cells. Failure to recognize cell surface-bound trinitrophenyl dextran.
Henkart PA; Schmitt-Verhulst M; Shearer GM
J Exp Med; 1977 Oct; 146(4):1068-78. PubMed ID: 70501
[TBL] [Abstract][Full Text] [Related]
2. H-2-restricted cytotoxic effectors generated in vitro by the addition of trinitrophenyl-conjugated soluble proteins.
Schmitt-Verhulst AM; Pettinelli CB; Henkart PA; Lunney JK; Shearer GM
J Exp Med; 1978 Feb; 147(2):352-68. PubMed ID: 75237
[TBL] [Abstract][Full Text] [Related]
3. Relationship between trinitrophenyl and H-2 antigens on trinitrophenyl-modified spleen cells. I. H-2 antigens on cells treated with trinitrobenzene sulfonic acid are derivatized.
Forman J; Vitetta ES; Hart DA; Klein J
J Immunol; 1977 Mar; 118(3):797-802. PubMed ID: 66272
[TBL] [Abstract][Full Text] [Related]
4. Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by H-2K and H-2D serological regions of the murine major histocompatibility complex.
Shearer GM; Rehn TG; Garbarino CA
J Exp Med; 1975 Jun; 141(6):1348-64. PubMed ID: 47900
[TBL] [Abstract][Full Text] [Related]
5. H-2-linked genetic control of murine T-cell-mediated lympholysis to autologous cells modified with low concentrations of trinitrobenzene sulfonate.
Shearer GM; Schmitt-Verhulst AM; Pettinelli CB; Miller MW; Gilheany PE
J Exp Med; 1979 Jun; 149(6):1407-23. PubMed ID: 109569
[TBL] [Abstract][Full Text] [Related]
6. On the role of the H-2 histocompatibility complex in determining the specificity of cytotoxic effector cells sensitized against syngeneic trinitrophenyl-modified targets.
Forman J
J Exp Med; 1975 Aug; 142(2):403-18. PubMed ID: 1079848
[TBL] [Abstract][Full Text] [Related]
7. T cell-mediated cytotoxicity against trinitrophenyl-modified cells: effect of glutaraldehyde treatment on the immunogenicity and antigenicity of trinitrophenyl-modified cells.
Forman J
J Immunol; 1977 May; 118(5):1755-62. PubMed ID: 404357
[TBL] [Abstract][Full Text] [Related]
8. Cell types required for H-2-restricted cytotoxic responses generated by trinitrobenzene sulfonate-modified syngeneic cells or trinitrophenyl-conjugated proteins.
Pettinelli CB; Schmitt-Verhulst AM; Shearer GM
J Immunol; 1979 Mar; 122(3):847-54. PubMed ID: 87418
[TBL] [Abstract][Full Text] [Related]
9. Relationship between trinitrophenol and H-2 antigens on trinitrophenyl-modified spleen cells. III. Quantitative aspects of trinitrophenol binding on cells treated with trinitrobenzene sulfonic acid.
Vitetta ES; Hart DA; Forman J
J Immunol; 1978 Sep; 121(3):997-1001. PubMed ID: 690447
[TBL] [Abstract][Full Text] [Related]
10. Cross-reactive lysis of trinitrophenyl (TNP)-derivatized H-2 incompatible target cells by cytolytic T lymphocytes generated against syngeneic TNP spleen cells.
Burakoff SJ; Germain RN; Benacerraf B
J Exp Med; 1976 Dec; 144(6):1609-20. PubMed ID: 1087327
[TBL] [Abstract][Full Text] [Related]
11. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.
Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC
Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193
[TBL] [Abstract][Full Text] [Related]
12. Relationship between trinitrophenyl and H-2 antigens on trinitrophenyl-modified spleen cells. II. Correlation between derivatization of H-2 antigens with trinitrophenyl and the ability of trinitrophenyl-modified cells to react functionally to the CML assay.
Forman J; Vitetta ES; Hart DA
J Immunol; 1977 Mar; 118(3):803-8. PubMed ID: 66273
[TBL] [Abstract][Full Text] [Related]
13. Receptor specificity of Ia-restricted T lymphoblasts activated against trinitrobenzene sulfonate-coupled spleen cells: recognition of distinct trinitrophenyl and Ia moieties.
Elliott BE; Palfree RG; Mundinger S
Cell Immunol; 1984 Mar; 84(1):121-37. PubMed ID: 6199119
[TBL] [Abstract][Full Text] [Related]
14. Studies on in-vivo priming of the trinitrophenyl-reactive cytotoxic effector-system. III. Are helper T cells involved in the in-vitro generation of cross-reactive as well as restricted cytotoxic responses?
Fujiwara H; Levy RB; Shearer GM
Immunobiology; 1982 Feb; 160(5):472-8. PubMed ID: 6978282
[TBL] [Abstract][Full Text] [Related]
15. The secondary cytotoxic response to trinitrophenyl (TNP) modified syngeneic lymphocytes: effectors generated in vitro differ from those generated in vivo.
Tagart V
Scand J Immunol; 1978; 8(2):91-7. PubMed ID: 705261
[TBL] [Abstract][Full Text] [Related]
16. Multiple H-2 linked immune response gene control of H-2 D-associated T-cell-mediated lympholysis to trinitrophenyl-modified autologous cells: Ir-like genes mapping to the left of I-A and within the I region.
Schmitt-Verhulst AM; Shearer GM
J Exp Med; 1976 Dec; 144(6):1701-6. PubMed ID: 1087329
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of T-cell clones specific for trinitrophenyl (TNP)-modified syngeneic spleen cells (TNP-self).
Arora PK; Hanna EE
Indian J Exp Biol; 1989 Oct; 27(10):843-8. PubMed ID: 2483952
[TBL] [Abstract][Full Text] [Related]
18. H-2 homology requirements for secondary cell-mediated lympholysis and miced lymphocyte reactions to TNP-modified syngeneic lymphocytes.
Schmitt-Verhulst AM; Garbarino CA; Shearer GM
J Immunol; 1977 Apr; 118(4):1420-7. PubMed ID: 66294
[TBL] [Abstract][Full Text] [Related]
19. Trinitrophenyl modification of H-2k and H-2b spleen cells results in enhanced serological detection of Kk-like determinants.
Levy RB; Dower SK; Shearer GM; Segal DM
J Exp Med; 1984 May; 159(5):1464-72. PubMed ID: 6201586
[TBL] [Abstract][Full Text] [Related]
20. Detection of shared H-2Kk and H-2Dk antigens that function as self determinants for cell-mediated lympholysis to trinitrophenyl-self.
Fujiwara H; Levy RB; Shearer GM
J Immunol; 1981 Apr; 126(4):1522-5. PubMed ID: 6162891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
